Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 65, no. 3, pp. –, 2017
Abstract
Keywords
- National Center for Biotechnology Information
- NCBI
- NLM
- MEDLINE
- humans
- pubmed abstract
- nih
- national institutes of health
- national library of medicine
- adult
- female
- male
- aged
- middle aged
- young adult
- Prospective Studies
- Bacterial
- drug resistance
- bacteria / drug effects
- feces / microbiology
- observational study
- anti-bacterial agents / pharmacology
- pmid:28369341
- doi:10.1093/cid/cix252
- jaroslaw bilinski
- pawel grzesiowski
- grzegorz w basak
- fecal microbiota transplantation* / adverse effects
- fecal microbiota transplantation* / statistics & numerical data
- gastrointestinal microbiome / physiology*
- hematologic diseases / therapy*
How to cite
Bilinski J; Grzesiowski P; Sorensen N; Madry K; Muszynski J; Robak K; Wroblewska M; Dzieciatkowski T; Dulny G; Dwilewicz-Trojaczek J; Wiktor-Jedrzejczak W; Basak GW. (2017). Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(3), –. http://www.ncbi.nlm.nih.gov/pubmed/28369341
j2017clinicalfecal
Type this key in a SciMatic manuscript or in Thesis Manager to cite this paper automatically.
References
No references are recorded for this paper yet.
